We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.95B
AUM Growth
+$323M
Cap. Flow
+$326M
Cap. Flow %
8.24%
Top 10 Hldgs %
35.62%
Holding
121
New
38
Increased
29
Reduced
19
Closed
34

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$89M
2
HCA icon
HCA Healthcare
HCA
+$87.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$86.2M
4
ELV icon
Elevance Health
ELV
+$82.1M
5
VMW
VMware, Inc
VMW
+$73.4M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$100M
2
MCK icon
McKesson
MCK
+$82.1M
3
SYK icon
Stryker
SYK
+$68M
4
PFE icon
Pfizer
PFE
+$67.6M
5
GILD icon
Gilead Sciences
GILD
+$63.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.61%
2 Technology 10.42%
3 Communication Services 8.14%
4 Industrials 7%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
51
Karyopharm Therapeutics
KPTI
$161M
$22.4M 0.57%
54,773
-20,164
-27% -$8.72M
DAL icon
52
Delta Air Lines
DAL
$57B
$22.1M 0.56%
538,650
+36,607
+7% +$1.6M
ALLY icon
53
Ally Financial
ALLY
$13.3B
$21.8M 0.55%
+970,811
New +$21.4M
BLUE
54
DELISTED
bluebird bio
BLUE
$21.4M 0.54%
9,818
-5,602
-36% -$11.4M
BPMC
55
DELISTED
Blueprint Medicines
BPMC
$20.9M 0.53%
+862,165
New +$24.6M
NFLX icon
56
Netflix
NFLX
$293B
$20M 0.51%
2,133,740
-338,380
-14% -$2.83M
BRKR icon
57
Bruker
BRKR
$9.14B
$19.9M 0.5%
972,911
+330,598
+51% +$6.68M
SIOX
58
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$19.4M 0.49%
+119,093
New +$20.2M
KITE
59
DELISTED
Kite Pharma, Inc.
KITE
$18.8M 0.48%
309,152
+133,158
+76% +$7.6M
ACHC icon
60
Acadia Healthcare
ACHC
$2.99B
$17.8M 0.45%
+227,174
New +$16.4M
ADAP
61
DELISTED
Adaptimmune Therapeutics
ADAP
$17.7M 0.45%
+965,515
New +$16.6M
HLF icon
62
Herbalife
HLF
$1.26B
$15.6M 0.4%
+567,650
New +$13.7M
HOUS
63
DELISTED
Anywhere Real Estate
HOUS
$14.9M 0.38%
+318,018
New +$14.8M
CYH icon
64
Community Health Systems
CYH
$383M
$13.5M 0.34%
+259,743
New +$11.7M
MOH icon
65
Molina Healthcare
MOH
$10.4B
$11.8M 0.3%
167,234
-137,300
-45% -$9.18M
PFE icon
66
Pfizer
PFE
$141B
$10.6M 0.27%
331,662
-2,074,486
-86% -$67.6M
ATML
67
DELISTED
ATMEL CORP
ATML
$10.1M 0.26%
+1,025,467
New +$9.03M
CHRS icon
68
Coherus Oncology
CHRS
$225M
$8.32M 0.21%
+288,079
New +$7.28M
PGND
69
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
$6.7M 0.17%
+233,662
New +$6.36M
HAPN
70
Happen Inc
HAPN
$2.16B
$6.42M 0.16%
+87,040
New +$7.78M
JUNO
71
DELISTED
Juno Therapeutics, Inc.
JUNO
$6.34M 0.16%
118,954
-395,631
-77% -$21M
PTCT icon
72
PTC Therapeutics
PTCT
$6.29B
$5.6M 0.14%
116,268
+64,939
+127% +$3.79M
ONCE
73
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$4.65M 0.12%
+77,141
New +$5.1M
FOMX
74
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$4.58M 0.12%
+446,909
New +$4.94M
HUM icon
75
PUT
Humana
HUM
$45.8B
$3.81M 0.1%
+687,100
New +$128M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2015 Portfolio in Review

As of Q2 2015, PFM Health Sciences held 121 positions worth $3.95B, up 8.9% from $3.63B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

PFM Health Sciences deployed $326M of net new capital in Q2 2015, opening 38 new positions and adding to 29 existing holdings. Its largest new stake was Aetna Inc: 779,930 shares worth $99.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 49% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bausch Health, an estimated $100M trimmed.

  • PFM Health Sciences's largest Q2 2015 buy was Aetna Inc: 779,930 shares worth $99.4M.
  • PFM Health Sciences added most to HCA Healthcare in Q2 2015, an estimated $87.3M increase.
  • PFM Health Sciences's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $100M.
  • PFM Health Sciences fully exited McKesson in Q2 2015, selling an estimated $82.1M.
  • PFM Health Sciences's ten largest holdings make up 36% of its $3.95B portfolio in Q2 2015.
  • PFM Health Sciences opened 38 new positions and closed 34 in Q2 2015.
  • PFM Health Sciences's portfolio value rose 8.9% quarter-over-quarter to $3.95B.

Based on PFM Health Sciences's 13F filing for Q2 2015, filed 14 Aug 2015.